{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:45:26Z","timestamp":1789573526742,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"V. G. F.","award":["1R01AI165671-01"],"award-info":[{"award-number":["1R01AI165671-01"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A. S. B.","award":["1RO1 AI146078"],"award-info":[{"award-number":["1RO1 AI146078"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A positive follow-up blood culture for methicillin-resistant Staphylococcus aureus (MRSA) while on seemingly appropriate therapy is a common and ominous development. However, the definition and management of persistent MRSA bacteremia is unstandardized. In this Opinion Paper, we identify the presence of bacteremia for &amp;gt; 1 calendar day as a \u201cworry point\u201d that should trigger an intensive diagnostic evaluation to identify metastatic infection sites. Next, we define the duration of MRSA bacteremia that likely constitutes antibiotic failure and outline a potential management algorithm for such patients. Finally, we propose pragmatic clinical trial designs to test treatment strategies for persistent MRSA bacteremia.<\/jats:p>","DOI":"10.1093\/cid\/ciac364","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T23:32:22Z","timestamp":1651707142000},"page":"1668-1674","source":"Crossref","is-referenced-by-count":47,"title":["Persistent methicillin-Resistant\n                    <i>Staphylococcus aureus<\/i>\n                    Bacteremia: Resetting the Clock for Optimal Management"],"prefix":"10.1093","volume":"75","author":[{"given":"Thomas L","family":"Holland","sequence":"first","affiliation":[{"name":"Department of Medicine, Duke University , Durham, North Carolina , USA"},{"name":"Duke Clinical Research Institute , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S","family":"Bayer","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA , Torrance, California , USA"},{"name":"The Geffen School of Medicine at UCLA , Los Angeles, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-0897","authenticated-orcid":false,"suffix":"Jr","given":"Vance G","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University , Durham, North Carolina , USA"},{"name":"Duke Clinical Research Institute , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2023012114293281700_ciac364-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clinical Microbiology Reviews"},{"key":"2023012114293281700_ciac364-B2","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/cid\/ciz112","article-title":"Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study","volume":"69","author":"Souli","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"2023012114293281700_ciac364-B4","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/cid\/ciaa801","article-title":"Risk factors for recurrent Staphylococcus aureus bacteremia","volume":"72","author":"Choi","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"2023012114293281700_ciac364-B6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein","volume":"190","author":"Fowler VG","year":"2004","journal-title":"J Infect Dis"},{"key":"2023012114293281700_ciac364-B7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/46.5.775","article-title":"Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy","volume":"46","author":"Drew","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2023012114293281700_ciac364-B8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B9","doi-asserted-by":"crossref","first-page":"e42-5","DOI":"10.1086\/506568","article-title":"Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants","volume":"43","author":"Hageman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cid\/ciy1144","article-title":"Clinical practice variation among adult infectious disease physicians in the management of Staphylococcus aureus bacteremia","volume":"69","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00365540510038488","article-title":"The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia","volume":"37","author":"Siegman-Igra","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"2023012114293281700_ciac364-B12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome","volume":"38","author":"Khatib","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"2023012114293281700_ciac364-B13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/CCM.0000000000001465","article-title":"A dysregulated balance of proinflammatory and anti-inflammatory host cytokine response early during therapy predicts persistence and mortality in Staphylococcus aureus bacteremia","volume":"44","author":"Minejima","year":"2016","journal-title":"Crit Care Med"},{"key":"2023012114293281700_ciac364-B14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.diagmicrobio.2010.02.026","article-title":"Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"67","author":"Neuner","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2023012114293281700_ciac364-B15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2023012114293281700_ciac364-B17","doi-asserted-by":"crossref","first-page":"ofz494","DOI":"10.1093\/ofid\/ofz494","article-title":"Intermittent negative blood cultures in Staphylococcus aureus bacteremia; a retrospective study of 1071 episodes","volume":"6","author":"Stewart","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023012114293281700_ciac364-B18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s15010-019-01339-w","article-title":"Is a single set of negative blood cultures sufficient to ensure clearance of bloodstream infection in patients with Staphylococcus aureus bacteremia? The skip phenomenon","volume":"47","author":"Fiala","year":"2019","journal-title":"Infection"},{"key":"2023012114293281700_ciac364-B19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal beta-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"key":"2023012114293281700_ciac364-B20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"2023012114293281700_ciac364-B21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciaa1081","article-title":"Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant Staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial","volume":"72","author":"Pujol","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/ciz750","article-title":"Combination therapy for MRSA bacteremia: to \u03b2 or not to \u03b2?","volume":"71","author":"Holland","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01888-13","article-title":"Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2023012114293281700_ciac364-B25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/phar.2034","article-title":"Early administration of adjuvant beta-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a retrospective, multicenter analysis","volume":"37","author":"Casapao","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2023012114293281700_ciac364-B26","doi-asserted-by":"crossref","first-page":"ofz077","DOI":"10.1093\/ofid\/ofz077","article-title":"The impact of concomitant empiric cefepime on patient outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections treated with vancomycin","volume":"6","author":"Zasowski","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023012114293281700_ciac364-B27","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/cid\/ciab452","article-title":"Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: does it work, which combination, and for which patients?","volume":"73","author":"Rose","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/cid\/ciy739","article-title":"A prognostic model of persistent bacteremia and mortality in complicated Staphylococcus aureus bloodstream infection","volume":"68","author":"Guimaraes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2020.07.040","article-title":"Mortality risk profiling of Staphylococcus aureus bacteremia by multi-omic serum analysis reveals early predictive and pathogenic signatures","volume":"182","author":"Wozniak","year":"2020","journal-title":"Cell"},{"key":"2023012114293281700_ciac364-B30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"2023012114293281700_ciac364-B31","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/cid\/ciab742","article-title":"Microbial cell-free DNA identifies etiology of bloodstream infections, persists longer than conventional blood cultures, and its duration of detection is associated with metastatic infection in patients with Staphylococcus aureus and gram-negative bacteremia","volume":"74","author":"Eichenberger","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B32","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1172\/JCI136577","article-title":"Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis","volume":"130","author":"Fowler VG","year":"2020","journal-title":"J Clin Invest"},{"key":"2023012114293281700_ciac364-B33","doi-asserted-by":"crossref","first-page":"e01863-20","DOI":"10.1128\/AAC.01863-20","article-title":"Bacteriophage AB-SA01 cocktail in combination with antibiotics against MRSA-VISA strain in an in vitro pharmacokinetic\/pharmactodynamic model","volume":"65","author":"Kebriaei","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023012114293281700_ciac364-B34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Fabijan","year":"2020","journal-title":"Nat Microbiol"},{"key":"2023012114293281700_ciac364-B35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler VG","year":"2006","journal-title":"N Engl J Med"},{"key":"2023012114293281700_ciac364-B36","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/cid\/ciz460","article-title":"The emperor's new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infections (PROVIDE)","volume":"70","author":"Lodise","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ejechocard\/jer023","article-title":"Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography","volume":"12","author":"Rasmussen","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2023012114293281700_ciac364-B39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jcmg.2015.02.027","article-title":"Use of transthoracic echocardiography in the management of low-risk Staphylococcus aureus bacteremia: results from a retrospective multicenter cohort study","volume":"8","author":"Showler","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023012114293281700_ciac364-B40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0735-1097(97)00250-7","article-title":"Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients","volume":"30","author":"Fowler","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2023012114293281700_ciac364-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cir320","article-title":"Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia","volume":"53","author":"Kaasch","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10096-013-1838-4","article-title":"Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis","volume":"32","author":"Incani","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023012114293281700_ciac364-B43","doi-asserted-by":"crossref","first-page":"e1151-e7","DOI":"10.1093\/cid\/ciaa1844","article-title":"Validation of VIRSTA and predicting risk of endocarditis using a clinical tool (PREDICT) scores to determine the priority of echocardiography in patients with Staphylococcus aureus bacteremia","volume":"73","author":"Peinado-Acevedo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B44","doi-asserted-by":"crossref","first-page":"e3859","DOI":"10.1093\/cid\/ciaa929","article-title":"Integration of FDG-PET\/CT in the diagnostic workup for Staphylococcus aureus bacteremia: a prospective interventional matched-cohort study","volume":"73","author":"Ghanem-Zoubi","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B45","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2967\/jnumed.117.191981","article-title":"(18)F-FDG PET\/CT optimizes treatment in Staphylococcus Aureus bacteremia and is associated with reduced mortality","volume":"58","author":"Berrevoets","year":"2017","journal-title":"J Nucl Med"},{"key":"2023012114293281700_ciac364-B46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"key":"2023012114293281700_ciac364-B47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/ciw098","article-title":"Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence","volume":"62","author":"Park","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.CCM.0B013E3181611F914","article-title":"Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia","volume":"36","author":"Crowley","year":"2008","journal-title":"Crit Care Med"},{"key":"2023012114293281700_ciac364-B49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciaa666","article-title":"Impact of systematic whole-body 18F-fluorodeoxyglucose PET\/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study","volume":"73","author":"Duval","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","article-title":"High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia","volume":"27","author":"Sharma","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023012114293281700_ciac364-B51","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","author":"Gasch","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2023012114293281700_ciac364-B52","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023012114293281700_ciac364-B53","doi-asserted-by":"crossref","first-page":"e02015","DOI":"10.1128\/AAC.02015-16","article-title":"Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"61","author":"Zasowski","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2023012114293281700_ciac364-B54","doi-asserted-by":"crossref","first-page":"e02483-18","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023012114293281700_ciac364-B55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/fmb-2019-0332","article-title":"Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, phase III trial","volume":"15","author":"Hamed","year":"2020","journal-title":"Future Microbiol"},{"key":"2023012114293281700_ciac364-B56","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01842-21","article-title":"A phase 1 study to evaluate the safety and pharmacokinetics following administration of single and multiple doses of the anti-staphylococcal lysin, LSVT-1701, in healthy adult subjects","author":"Wire","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2023012114293281700_ciac364-B57","doi-asserted-by":"crossref","first-page":"ofaa151","DOI":"10.1093\/ofid\/ofaa151","article-title":"A narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: yay or nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac364\/44317851\/ciac364.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1668\/48809544\/ciac364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/9\/1668\/48809544\/ciac364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T09:30:17Z","timestamp":1674293417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/9\/1668\/6583152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5,10]]},"published-print":{"date-parts":[[2022,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac364","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,5,10]]}}}